149 related articles for article (PubMed ID: 29496040)
1. Podoplanin emerges as a functionally relevant oral cancer biomarker and therapeutic target.
Retzbach EP; Sheehan SA; Nevel EM; Batra A; Phi T; Nguyen ATP; Kato Y; Baredes S; Fatahzadeh M; Shienbaum AJ; Goldberg GS
Oral Oncol; 2018 Mar; 78():126-136. PubMed ID: 29496040
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor-II mRNA binding protein-3 and podoplanin expression are associated with bone invasion and prognosis in oral squamous cell carcinoma.
Hwang YS; Ahn SY; Moon S; Zheng Z; Cha IH; Kim J; Zhang X
Arch Oral Biol; 2016 Sep; 69():25-32. PubMed ID: 27232357
[TBL] [Abstract][Full Text] [Related]
3. Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms.
Ochoa-Alvarez JA; Krishnan H; Pastorino JG; Nevel E; Kephart D; Lee JJ; Retzbach EP; Shen Y; Fatahzadeh M; Baredes S; Kalyoussef E; Honma M; Adelson ME; Kaneko MK; Kato Y; Young MA; Deluca-Rapone L; Shienbaum AJ; Yin K; Jensen LD; Goldberg GS
Oncotarget; 2015 Apr; 6(11):9045-60. PubMed ID: 25826087
[TBL] [Abstract][Full Text] [Related]
4. [Podoplanin expression in oral squamous cell carcinoma and leukoplakia and its correlation with lymph vessels density].
Zhang G; Guo ZL; Gao Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Aug; 44(8):488-91. PubMed ID: 19961757
[TBL] [Abstract][Full Text] [Related]
5. Extracellular heat shock protein A9 is a novel interaction partner of podoplanin in oral squamous cell carcinoma cells.
Tsuneki M; Maruyama S; Yamazaki M; Xu B; Essa A; Abé T; Babkair H; Cheng J; Yamamoto T; Saku T
Biochem Biophys Res Commun; 2013 Apr; 434(1):124-30. PubMed ID: 23541579
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical Expression of Podoplanin in Clinical Variants of Oral Leukoplakia and Its Correlation With Epithelial Dysplasia.
D'souza B; Nayak R; Kotrashetti VS
Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):132-139. PubMed ID: 27153448
[TBL] [Abstract][Full Text] [Related]
7. Podoplanin-mediated cell adhesion through extracellular matrix in oral squamous cell carcinoma.
Tsuneki M; Yamazaki M; Maruyama S; Cheng J; Saku T
Lab Invest; 2013 Aug; 93(8):921-32. PubMed ID: 23817087
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of podoplanin expression in oral squamous cell carcinoma--a regression model auxiliary to UICC classification.
Seki S; Fujiwara M; Matsuura M; Fujita S; Ikeda H; Umeda M; Asahina I; Ikeda T
Pathol Oncol Res; 2014 Jul; 20(3):521-8. PubMed ID: 24281769
[TBL] [Abstract][Full Text] [Related]
9. Podoplanin promotes cell migration via the EGF-Src-Cas pathway in oral squamous cell carcinoma cell lines.
Inoue H; Miyazaki Y; Kikuchi K; Yoshida N; Ide F; Ohmori Y; Tomomura A; Sakashita H; Kusama K
J Oral Sci; 2012 Sep; 54(3):241-50. PubMed ID: 23047035
[TBL] [Abstract][Full Text] [Related]
10. Podoplanin expression in tumor-free resection margins of oral squamous cell carcinomas: an immunohistochemical and fractal analysis study.
Margaritescu C; Raica M; Pirici D; Simionescu C; Mogoanta L; Stinga AC; Stinga AS; Ribatti D
Histol Histopathol; 2010 Jun; 25(6):701-11. PubMed ID: 20376776
[TBL] [Abstract][Full Text] [Related]
11. Role of podoplanin in potentially malignant disorders and oral squamous cell carcinoma and its correlation with lymphangiogenesis.
Parhar S; Kaur H; Vashist A; Verma S
Indian J Cancer; 2015; 52(4):617-22. PubMed ID: 26960495
[TBL] [Abstract][Full Text] [Related]
12. Podoplanin promotes cancer-associated thrombosis and contributes to the unfavorable overall survival in an ectopic xenograft mouse model of oral cancer.
Lee HY; Yu NY; Lee SH; Tsai HJ; Wu CC; Cheng JC; Chen DP; Wang YR; Tseng CP
Biomed J; 2020 Apr; 43(2):146-162. PubMed ID: 32441651
[TBL] [Abstract][Full Text] [Related]
13. Expression of podoplanin in the invasion front of oral squamous cell carcinoma is not prognostic for survival.
de Vicente JC; Santamarta TR; Rodrigo JP; García-Pedrero JM; Allonca E; Blanco-Lorenzo V
Virchows Arch; 2015 May; 466(5):549-58. PubMed ID: 25726183
[TBL] [Abstract][Full Text] [Related]
14. Podoplanin expression correlates with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynx.
Huber GF; Fritzsche FR; Züllig L; Storz M; Graf N; Haerle SK; Jochum W; Stoeckli SJ; Moch H
Int J Cancer; 2011 Sep; 129(6):1404-9. PubMed ID: 21105028
[TBL] [Abstract][Full Text] [Related]
15. Podoplanin is a useful prognostic marker and indicates better differentiation in lung squamous cell cancer patients? A systematic review and meta-analysis.
Hu L; Zhang P; Mei Q; Sun W; Zhou L; Yin T
BMC Cancer; 2020 May; 20(1):424. PubMed ID: 32408907
[TBL] [Abstract][Full Text] [Related]
16. Podoplanin promotes cell proliferation, survival, and migration of canine non-tonsillar squamous cell carcinoma.
Shinada M; Kato D; Tsuboi M; Ikeda N; Aoki S; Iguchi T; Li T; Kodera Y; Ota R; Koseki S; Shibahara H; Takahashi Y; Hashimoto Y; Chambers JK; Uchida K; Noguchi S; Kato Y; Nishimura R; Nakagawa T
J Vet Med Sci; 2023 Oct; 85(10):1068-1073. PubMed ID: 37544715
[TBL] [Abstract][Full Text] [Related]
17. Podoplanin and VEGF-C immunoexpression in oral squamous cell carcinomas: prognostic significance.
dos Santos Almeida A; Oliveira DT; Pereira MC; Faustino SE; Nonogaki S; Carvalho AL; Kowalski LP
Anticancer Res; 2013 Sep; 33(9):3969-76. PubMed ID: 24023336
[TBL] [Abstract][Full Text] [Related]
18. Correlation between podoplanin expression and extracapsular spread in squamous cell carcinoma of the oral cavity using subjective immunoreactivity scores and semiquantitative image analysis.
Mermod M; Bongiovanni M; Petrova TV; Dubikovskaya EA; Simon C; Tolstonog G; Monnier Y
Head Neck; 2017 Jan; 39(1):98-108. PubMed ID: 27437903
[TBL] [Abstract][Full Text] [Related]
19. Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy.
Kawaguchi H; El-Naggar AK; Papadimitrakopoulou V; Ren H; Fan YH; Feng L; Lee JJ; Kim E; Hong WK; Lippman SM; Mao L
J Clin Oncol; 2008 Jan; 26(3):354-60. PubMed ID: 18202409
[TBL] [Abstract][Full Text] [Related]
20. Podoplanin--a novel marker in oral carcinogenesis.
Swain N; Kumar SV; Routray S; Pathak J; Patel S
Tumour Biol; 2014 Sep; 35(9):8407-13. PubMed ID: 24964963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
